Oishii Plus Co. Ltd. announced that it has raised in a round of funding on May 18, 2023. the transaction included participation from new investor, Rohto Pharmaceutical Co.,Ltd.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,069 JPY | +1.09% | +2.88% | +7.95% |
Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.95% | 4.42B | |
+26.47% | 664B | |
+26.74% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.43% | 234B | |
+4.71% | 199B | |
-9.53% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- 4527 Stock
- News Rohto Pharmaceutical Co.,Ltd.
- Oishii Plus Co. Ltd. announced that it has received funding from Rohto Pharmaceutical Co.,Ltd.